The Role of Regional Anesthesia During the SARS-CoV2 Pandemic: Appraisal of Clinical, Pharmacological and Organizational Aspects.
COVID-19
anesthesia
conduction
coronavirus
regional anaesthesia
regional anesthesia
severe acute respiratory syndrome coronavirus 2
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2021
2021
Historique:
received:
19
06
2020
accepted:
28
04
2021
entrez:
21
6
2021
pubmed:
22
6
2021
medline:
22
6
2021
Statut:
epublish
Résumé
The severe acute respiratory syndrome coronavirus SARS-CoV2 is spreading over millions of people worldwide, leading to thousands of deaths, even among the healthcare providers. Italy has registered the deaths of 337 physicians and more than 200 nurses as of March 14, 2021. Anesthesiologists are at higher risk as they are the care providers in both ICU and operating rooms.Although the vaccination of healthcare providers has been the prioirity, physicians are still continually exposed to the virus and potentially risk contagion and must thus protect themselves and their patients from the risks of infection while providing the best care to their surgical patients.Regional anesthesia allows for a reduction in airway manipulation, reducing environmental contamination as a result. Furthermore, regional anesthesia reduces the opioid requirements as well as the muscle paralysis due to muscle-relaxants and should be recommended whenever possible in COVID-19 patients. Our aim is to evaluate the advantages and criticisms of regional anesthesia in the management of surgical patients in the pandemic age.
Identifiants
pubmed: 34149401
doi: 10.3389/fphar.2021.574091
pii: 574091
pmc: PMC8213435
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
574091Informations de copyright
Copyright © 2021 Cappelleri, Fanelli, Ghisi, Russo, Giorgi, Torrano, Lo Bianco, Salomone and Fumagalli.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Can J Anaesth. 2020 Jun;67(6):655-663
pubmed: 32180175
Br J Anaesth. 2020 Jun;124(6):670-675
pubmed: 32234250
Anesth Analg. 2020 Jul;131(1):7-15
pubmed: 32265365
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
F1000Res. 2016 Oct 11;5:
pubmed: 27785357
Public Health. 2021 Apr;193:57-60
pubmed: 33743214
Lancet. 2020 Jul 4;396(10243):27-38
pubmed: 32479829
Reg Anesth Pain Med. 2018 Apr;43(3):225-262
pubmed: 29278603
Anesth Analg. 2017 Jan;124(1):336-345
pubmed: 27918333
J Clin Virol. 2020 Jun;127:104362
pubmed: 32305883
Brain Behav Immun. 2020 Jul;87:18-22
pubmed: 32240762
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112
J Thromb Haemost. 2020 Jul;18(7):1738-1742
pubmed: 32302438
Anesth Analg. 2020 Jul;131(1):e25-e26
pubmed: 32243298
Br J Clin Pharmacol. 2018 Oct;84(10):2415-2421
pubmed: 29959798
Reg Anesth Pain Med. 2020 Jul;45(7):536-543
pubmed: 32471930
Reg Anesth Pain Med. 2006 Jul-Aug;31(4):324-33
pubmed: 16857552
JAMA Netw Open. 2020 Apr 24;3(4):e208857
pubmed: 32330277
Anesth Analg. 2018 Mar;126(3):928-944
pubmed: 29099429
Reg Anesth Pain Med. 2012 Sep-Oct;37(5):537-44
pubmed: 22854396
Clin Pharmacol Ther. 2008 Oct;84(4):506-12
pubmed: 19238656
Anesth Analg. 2019 Jan;128(1):5-7
pubmed: 30550467